Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on January 5, 2006
Accepted on July 24, 2006
Opposing Activities Protect Against Age Onset Proteotoxicity
Ehud Cohen 1, Jan Bieschke 2, Rhonda M. Perciavalle 1, Jeffery W. Kelly 2, Andrew Dillin 1*
1 Molecular and Cell Biology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037, USA. 2 Department of Chemistry and The Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.
* To whom correspondence should be addressed.
Andrew Dillin , E-mail: dillin{at}salk.edu
Aberrant protein aggregation is a common feature of late-onsetneurodegenerative diseases, including Alzheimer disease (AD)which is associated with the misassembly of the A1-42 peptide.Aggregation-mediated A1-42 toxicity was reduced in C. eleganswhen aging was slowed by decreased insulin/insulin growth factor(IGF)-1-like signaling (IIS). The downstream transcription factors,heat shock factor-1 (HSF-1) and DAF-16 regulate opposing disaggregationand aggregation activities to promote cellular survival in responseto constitutive toxic protein aggregation. Because the IIS pathwayis central to the regulation of longevity and youthfulness inworms, flies and mammals, these results suggest a mechanisticlink between the aging process and aggregation-mediated proteotoxicity.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Lisa D. Chong (19 September 2006) Sci. STKE2006 (353), tw326.
[DOI: 10.1126/stke.3532006tw326] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Investigating the Mechanism of Peptide Aggregation: Insights from Mixed Monte Carlo-Molecular Dynamics Simulations.
Proteasomal adaptation to environmental stress links resistance to proteotoxicity with longevity in Caenorhabditis elegans.
C. Yun, A. Stanhill, Y. Yang, Y. Zhang, C. M. Haynes, C.-F. Xu, T. A. Neubert, A. Mor, M. R. Philips, and D. Ron (2008)
PNAS
105, 7094-7099
|Abstract »|Full Text »|PDF »
Insolubility of Disrupted-in-Schizophrenia 1 Disrupts Oligomer-Dependent Interactions with Nuclear Distribution Element 1 and Is Associated with Sporadic Mental Disease.
S. R. Leliveld, V. Bader, P. Hendriks, I. Prikulis, G. Sajnani, J. R. Requena, and C. Korth (2008)
J. Neurosci.
28, 3839-3845
|Abstract »|Full Text »|PDF »
Adapting Proteostasis for Disease Intervention.
W. E. Balch, R. I. Morimoto, A. Dillin, and J. W. Kelly (2008)
Science
319, 916-919
|Abstract »|Full Text »|PDF »
Differential display of DNA-binding proteins reveals heat-shock factor 1 as a circadian transcription factor.
H. Reinke, C. Saini, F. Fleury-Olela, C. Dibner, I. J. Benjamin, and U. Schibler (2008)
Genes & Dev.
22, 331-345
|Abstract »|Full Text »|PDF »
Suppression of in Vivo -Amyloid Peptide Toxicity by Overexpression of the HSP-16.2 Small Chaperone Protein.
V. Fonte, D. R. Kipp, J. Yerg III, D. Merin, M. Forrestal, E. Wagner, C. M. Roberts, and C. D. Link (2008)
J. Biol. Chem.
283, 784-791
|Abstract »|Full Text »|PDF »
Sirtuin 2 Inhibitors Rescue {alpha}-Synuclein-Mediated Toxicity in Models of Parkinson's Disease.
T. F. Outeiro, E. Kontopoulos, S. M. Altmann, I. Kufareva, K. E. Strathearn, A. M. Amore, C. B. Volk, M. M. Maxwell, J.-C. Rochet, P. J. McLean, et al. (2007)
Science
317, 516-519
|Abstract »|Full Text »|PDF »
Mad Fly Disease.
J. Chandran and P. Lewis (2007)
J. Neurosci.
27, 971-972
|Full Text »|PDF »
Amyloid-{beta}-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans.
Y. Wu, Z. Wu, P. Butko, Y. Christen, M. P. Lambert, W. L. Klein, C. D. Link, and Y. Luo (2006)
J. Neurosci.
26, 13102-13113
|Abstract »|Full Text »|PDF »
Stress, aging, and neurodegenerative disease..
R. I. Morimoto (2006)
N. Engl. J. Med.
355, 2254-2255
|Full Text »|PDF »